Glaxosmithkline Company Timeline (GSK)

LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears

(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike across the pond.

UK dividends calendar - next 7 days

London's FTSE 100 inches lower as Middle East concerns weigh

July 1 (Reuters) - The UK's ​blue-chip ⁠FTSE 100 slipped on Wednesday, with ​healthcare and energy shares leading declines, as investors monitored the latest setback in U.S.-Iran talks.

LONDON MARKET CLOSE: Mid-caps shine but AB Foods holds back FTSE 100

(Alliance News) - Stocks ended mixed in London on Wednesday with US rate hike worries and a decline in Primark owner Associated British Foods hitting blue-chips, while mid-caps prospered.

LONDON BROKER RATINGS: UBS, RBC and Citi cut easyJet; UBS lowers Mondi

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

LONDON BROKER RATINGS: RBC ups Central Asia Metals to 'sector perform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts.

US military requires flu vaccine for some after outbreak in Texas training center

June 24 (Reuters) - The U.S. military has ​resumed ⁠requiring flu vaccines for some service ​members in an exception to Defense Secretary Pete Hegseth's guidance declaring the shots ​voluntary two ‌mo...

GSK launches tender offer for USD10.6 billion purchase of Nuvalent

(Alliance News) - GSK PLC on Wednesday said it has launched the tender offer for its previously announced acquisition of US-based cancer drug developer Nuvalent Inc for USD10.6 billion.

IN BRIEF: GSK executives, including non-exec chair, buy shares

GSK PLC - London-based pharmaceuticals firm - Non-Executive Chair Jonathan Symonds buys 1,550 shares at GBP19.35 for total GBP29,992.50 last Friday. Director Vishal Sikka buys 1,266 ADS for USD50.69 e...

Moderna's mRNA flu vaccine backed by FDA advisers

* ⁠FDA advisers back mFlusiva's benefits for adults 50 and up

GSK says US FDA approves urinary tract infection treatment Utebzi

(Alliance News) - GSK PLC and Spero Therapeutics Inc on Wednesday said that the US Food & Drug Administration has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract inf...

GSK drug momelotinib gains regulatory nods as VEXAS treatment

(Alliance News) - GSK PLC on Friday announced that momelotinib has received orphan drug designation from the US Food & Drug Administration, and the European Medicines Agency, to treat VEXAS syndrome.

GSK's momelotinib receives orphan drug designation from US and EU watchdogs

(Sharecast News) - Drugmaker GSK said on Friday that its JAK inhibitor momelotinib has been granted orphan drug designation by both the US Food and Drug Administration and the European Medicines Agenc...

LONDON BRIEFING: UK economy contracts in April; Flutter to leave LSE

(Alliance News) - The UK economy contracts 0.1% in April, Flutter Entertainment says it will delist from the London Stock Exchange in August, while Alternative Income REIT's largest shareholder makes...

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

* Deal deepens oncology push under CEO Luke Miels

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

* Deal deepens oncology push under CEO Luke Miels

UK's FTSE 100 hits over three-week low as banks, energy stocks sag

June 9 (Reuters) - Britain's ​blue-chip FTSE ⁠100 hit its lowest since mid-May ​on Tuesday, bogged down by losses in heavyweight lenders HSBC and Standard Chartered, while ​energy giants ‌also lost gr...

LONDON MARKET MIDDAY: FTSE 100 lags Europe as oil majors, GSK weigh

(Alliance News) - Stock prices in London were mixed at midday on Tuesday, as the FTSE 100 lagged European peers despite renewed optimism for a peace deal in the Middle East, as oil majors and GSK weig...

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday.

GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover

* Deal values cancer drug developer Nuvalent at $124 per share

LONDON MARKET OPEN: FTSE 100 down as GSK buys US drugmaker Nuvalent

(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent for USD10.6 billion.

UPDATE: GSK buys cancer drug developer Nuvalent for USD10.6 billion

(Alliance News) - GSK PLC on Tuesday said it has agreed to US-based cancer drug developer Nuvalent Inc for USD10.6 billion.

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housin...

GSK to buy Boston-based biopharmaceutical firm Nuvalent for $10.6bn

(Sharecast News) - GSK said on Tuesday that it has agreed to buy Boston-based oncology-focused biopharmaceutical firm Nuvalent for $10.6bn (£7.9bn).

What's Hot 9th June 2026

With the US 'Tech Bros' vying for historic IPO's, why is there caution about stratospheric valuations, which UK companies are flirting with M&A and why are some trading updates making the city lo...